| Product Code: ETC9513353 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Suriname hematopoietic agents import market saw a significant increase in concentration, with top exporters being Peru, Netherlands, USA, Brazil, and Germany. Despite a negative growth rate from 2023 to 2024, the compound annual growth rate for 2020-2024 stands at 2.08%. The high concentration of Herfindahl-Hirschman Index (HHI) in 2023 further intensified in 2024, indicating a competitive landscape dominated by these key exporting countries. This trend suggests potential challenges and opportunities for market players operating in Suriname hematopoietic agents sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Hematopoietic Agents Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Hematopoietic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Hematopoietic Agents Market - Industry Life Cycle |
3.4 Suriname Hematopoietic Agents Market - Porter's Five Forces |
3.5 Suriname Hematopoietic Agents Market Revenues & Volume Share, By Class, 2021 & 2031F |
3.6 Suriname Hematopoietic Agents Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.7 Suriname Hematopoietic Agents Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Suriname Hematopoietic Agents Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Suriname Hematopoietic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Suriname Hematopoietic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood disorders and hematologic diseases in Suriname |
4.2.2 Growing awareness about the importance of hematopoietic agents in the treatment of various conditions |
4.2.3 Technological advancements leading to the development of more effective hematopoietic agents |
4.3 Market Restraints |
4.3.1 High cost associated with hematopoietic agents leading to affordability issues for patients |
4.3.2 Limited healthcare infrastructure and access to specialized treatment centers in Suriname |
5 Suriname Hematopoietic Agents Market Trends |
6 Suriname Hematopoietic Agents Market, By Types |
6.1 Suriname Hematopoietic Agents Market, By Class |
6.1.1 Overview and Analysis |
6.1.2 Suriname Hematopoietic Agents Market Revenues & Volume, By Class, 2021- 2031F |
6.1.3 Suriname Hematopoietic Agents Market Revenues & Volume, By Agents for Anemia, 2021- 2031F |
6.1.4 Suriname Hematopoietic Agents Market Revenues & Volume, By Hematopoietic Growth Factors, 2021- 2031F |
6.1.5 Suriname Hematopoietic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Suriname Hematopoietic Agents Market, By Indications |
6.2.1 Overview and Analysis |
6.2.2 Suriname Hematopoietic Agents Market Revenues & Volume, By Iron Deficiency Anemia, 2021- 2031F |
6.2.3 Suriname Hematopoietic Agents Market Revenues & Volume, By Megaloblastic Anemia, 2021- 2031F |
6.2.4 Suriname Hematopoietic Agents Market Revenues & Volume, By Hematopoietic Growth Factors Disorders, 2021- 2031F |
6.2.5 Suriname Hematopoietic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Suriname Hematopoietic Agents Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Suriname Hematopoietic Agents Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Suriname Hematopoietic Agents Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Suriname Hematopoietic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Suriname Hematopoietic Agents Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Suriname Hematopoietic Agents Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Suriname Hematopoietic Agents Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Suriname Hematopoietic Agents Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 Suriname Hematopoietic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Suriname Hematopoietic Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Suriname Hematopoietic Agents Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Suriname Hematopoietic Agents Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Suriname Hematopoietic Agents Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Suriname Hematopoietic Agents Market Import-Export Trade Statistics |
7.1 Suriname Hematopoietic Agents Market Export to Major Countries |
7.2 Suriname Hematopoietic Agents Market Imports from Major Countries |
8 Suriname Hematopoietic Agents Market Key Performance Indicators |
8.1 Number of new clinical trials for hematopoietic agents conducted in Suriname |
8.2 Adoption rate of advanced hematopoietic agents by healthcare facilities in Suriname |
8.3 Number of partnerships between local healthcare providers and international pharmaceutical companies for hematopoietic agents development |
9 Suriname Hematopoietic Agents Market - Opportunity Assessment |
9.1 Suriname Hematopoietic Agents Market Opportunity Assessment, By Class, 2021 & 2031F |
9.2 Suriname Hematopoietic Agents Market Opportunity Assessment, By Indications, 2021 & 2031F |
9.3 Suriname Hematopoietic Agents Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Suriname Hematopoietic Agents Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Suriname Hematopoietic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Suriname Hematopoietic Agents Market - Competitive Landscape |
10.1 Suriname Hematopoietic Agents Market Revenue Share, By Companies, 2024 |
10.2 Suriname Hematopoietic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here